test

Justin Hirsch

@Octagon Capital Advisors Lp

Latest period2024 - Q3ReportedManaged Assets$642.902MTotal holdings41
Assets growth rate1.05%Assets growth rate (2-Q avg)-11.35%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Octagon Capital Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 41 positions.

Assets under management

The assets under management (AUM) of Octagon Capital Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 642.902M in assets, with a quarterly growth rate of 1.05% and a 2-quarter average growth rate of -11.35%. The portfolio is managed by Justin Hirsch, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
APLSApellis Pharmaceuticals Inc
Recent Activity
Decreased -6.93%
13.49%
$86.721M
3.007M shares@ $28.84 avg price
VRNAVerona Pharma Plc
Recent Activity
Decreased -3.16%
8.22%
$52.799M
1.835M shares@ $28.77 avg price
INSMInsmed Inc
Recent Activity
Decreased -23.7%
7.8%
$50.138M↑ Call
686,820 shares@ $73.0 avg price
CNTACentessa Pharmaceuticals Plc
Recent Activity
Decreased -14.2%
5.01%
$32.173M
2.012M shares@ $15.99 avg price
CATXPerspective Therapeutics Inc
Recent Activity
Decreased -10%
2.96%
$18.987M
1.422M shares@ $13.35 avg price
BBIOBridgebio Pharma Inc
Recent Activity
Decreased -20%
2.19%
$14.054M
552,000 shares@ $25.46 avg price
DYNDyne Therapeutics Inc
Recent Activity
Decreased -77.75%
1.47%
$9.437M
262,726 shares@ $35.93 avg price
PRAXPraxis Precision Medicines I
Recent Activity
Decreased -50%
1.17%
$7.48M
130,000 shares@ $57.54 avg price
IPSCCentury Therapeutics Inc
Recent Activity
Decreased -50%
0.18%
$1.14M
666,825 shares@ $1.72 avg price
NKTXNkarta Inc
Recent Activity
Decreased -50%
0.09%
$542,400
120,000 shares@ $4.52 avg price